Obsessive-compulsive disorder: A review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V

Depression and Anxiety

Volumn 27, Issue 6, 2010, Pages 507-527

  Leckman, James F ^a   Denys, Damiaan ^b,c   Simpson, H Blair ^d   Mataix Cols, David ^e   Hollander, Eric ^f   Saxena, Sanjaya ^g   Miguel, Euripedes C ^h   Rauch, Scott L ⁱ   Goodman, Wayne K ^j   Phillips, Katharine A ^k   Stein, Dan J ^k,l  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF SÃO PAULO   (Brazil)

ⁱ HARVARD UNIVERSITY   (United States)

^j MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^k BROWN UNIVERSITY   (United States)

^l UNIVERSITY OF CAPE TOWN   (South Africa)

more..

Author keywords

DSM V; Early onset; Nosology; Obsessive compulsive disorder; Symptom dimensions; Tic disorders

Indexed keywords

CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; SEROTONIN UPTAKE INHIBITOR;

BEHAVIOR THERAPY; CLINICAL FEATURE; COGNITIVE THERAPY; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; HUMAN; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; REVIEW; SYMPTOM; TREATMENT RESPONSE; VALIDITY;

BRAIN; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; NEUROPSYCHOLOGICAL TESTS; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS;

EID: 77953496584     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20669     Document Type: Review

References (185)

1. Flament MF, Whitaker A, Rapoport JL, et al. Obsessive compulsive disorder in adolescence: An epidemiological study. J Am Acad Child Adolesc Psychiatry 1988;27:764-771.
2. Fontenelle LF, Mendlowicz MV, Versiani M. The descriptive epidemiology of obsessive-compulsive disorder. Prog Neuropsy-chopharmacol Biol Psychiatry 2006;30:327-337.
3. Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry 2010;15:53-63.
4. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Text rev. Washington, DC: American Psychiatric Association; 2000.
5. International Classification of Diseases. Geneva, Switzerland: World Health Organization; 1992.
6. Mataix-Cols D, Frost RO, Pertusa A, et al. Hoarding disorder: A new diagnosis for DSM-V? Depress Anxiety, in press.
7. Rachman S, De Silva P. Abnormal and normal obsessions. Behav Res Ther 1978;16:233-248.
8. Fullana M, Mataix-Cols D, Caspi A, et al. Obsessions and compulsions in the community: Prevalence, interference, helpseeking, temporal stability and co-occurring psychiatric conditions. Am J Psychiatry 2009;166:329-336.
9. de Bruijn C, Beun S, de Graaf R, et al. Subthreshold symptoms and obsessive compulsive disorders: Evaluating the diagnostic threshold. Psychol Med 2009 Sep 7:1-9. [Epub ahead of print].
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association; 1952.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 2nd ed. Washington, DC: American Psychiatric Association; 1968.
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. Washington, DC: American Psychiatric Association; 1980.
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
14. American Psychiatric Association. DSM-IV Options Book. Washington, DC: American Psychiatric Association; 1991.
15. Kupfer DJ, First MB, Regier DA, eds. A Research Agenda for DSM-V. Washington, DC: American Psychiatric Association; 2002.
16. Phillips KA, Stein DJ, Rauch SL, et al. Should an obsessive-compulsive spectrum grouping of disorders be included in DSMV? Depress Anxiety, in press.
17. Stein DJ, Fineberg NA, Bienvenu OJ, et al. Should OCD be classified as an anxiety disorder in DSM-V? Depress Anxiety, in press.
18. Storch EA, Mariaskin A, Murphy TK. Psychotherapy for obsessive-compulsive disorder. Curr Psychiatry Rep. 2009;11: 296-301.
19. Kozak MJ, Foa EB. Mastery of Obsessive-compulsive Disorder: A Cognitive-Behavioral Approach. San Antonio: The Psychological Corporation. Harcourt Brace & Company; 1997.
20. Stein DJ, Denys D, Gloster AT, et al. Obsessive-compulsive disorder: Diagnostic and treatment issues. Psychiatr Clin North Am 2009;32:665-685.
21. Webster Dictionary Webster's Third New International Dictionary, Unabridged. New York: Merriam-Webster; 2000.
22. Hoogduin K. On the diagnosis of obsessive-compulsive disorder. Am J Psychother 1986;40:36-51.
23. Lewis-Fernández R. Editorial: The cultural formulation. Transcult Psychiatry 2009;46:379-382.
24. Foa EB, Jenike M, Kozak MJ, et al. Obsessive Compulsive Disorder. In: Widiger TA, Pincus HA, Ross R, First MB, Davis WW, eds. DSM IV Sourcebook, Volume 2, pp. 552-575. Washington, DC: American Psychiatric Association, 1996.
25. Boulougouris JC, Rabavilas AD, Stefanis C. Psychophysiological responses in obsessive-compulsive patients. Behav Res Ther 1977;15:221-230.
26. Rabavilas AD, Boulougouris JC. Physiological accompaniments of ruminations, flooding and thought-stopping in obsesssive patients. Behav Res Ther 1974;12:239-243.
27. Rachman SJ, Hodgson RJ. Obsessions and Compulsions. Englewood Cliffs, NJ: Prentice-Hall; 1980.
28. Kozak MJ, Rossi M, McCarthy PR, Foa EB. Effects of imipramine on the autonomic responses of obsessive-compulsives to auditory tones. Biol Psychiatry 1989;26:707-716.
29. Hornsveld RH, Kraaimaat FW, van Dam-Baggen RM. Anxiety/discomfort and handwashing in obsessive-compulsive and psychiatric control patients. Behav Res Ther 1979;17:223-228.
30. Purcell CE, Arrigo BA. The Psychology of Lust Murder: Paraphilia, Sexual Killing, and Serial Homicide. New York: Academic Press; 2006.
31. Foa EB, Liebowitz MR, Kozak MJ, et al. Randomized, placebocontrolled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry 2005;162:151-161.
32. Pediatric OCD Treatment Study (POTS) Team. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: The Pediatric OCD Treatment Study (POTS) randomized controlled trial. J Am Med Assoc 2004;292:1969-1976.
33. Mancebo MC, Greenberg B, Grant JE, et al. Correlates of occupational disability in a clinical sample of obsessive-compulsive disorder. Compr Psychiatry 2008;49:43-50.
34. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989;46:1006-1011.
35. Goodman WK, Price LH, Rasmussen SA, Mazure C. The Yale-Brown Obsessive Compulsive Scale II: Validity. Arch Gen Psychiatry 1989;46:1012-1016.
36. Foa EB, Kozak MJ, Goodman WK, et al. DSM-IV field trial: Obsessive-compulsive disorder. Am J Psychiatry 1995;152: 90-96.
37. Eisen JL, Phillips KA, Coles ME, Rasmussen SA. Insight in obsessive compulsive disorder and body dysmorphic disorder. Compr Psychiatry 2004;45:10-1536.
38. Skoog G, Skoog I. A 40-year follow-up of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1999;56: 121-127.
39. Eisen JL, Phillips KA, Baer L, Beer DA, Atala KD, Rasmussen SA. The Brown Assessment of Beliefs Scale: Reliability and validity. Am J Psychiatry 1998;155:102-108.
40. Muris P, Merckelbach H, Clavan M. Abnormal and normal compulsions. Behav Res Ther 1997;35:249-252.
41. Phillips KA, Wilhelm S, Koran LM, et al. Body Dysmorphic Disorder: Some key issues for DSM-V, Depress Anxiety, in press.
42. Crino R, Slade T, Andrews G. The changing prevalence and severity of obsessive-compulsive disorder criteria from DSM-III to DSM-IV. Am J Psychiatry 2005;162:876-882.
43. Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases. Am J Psychiatry 1998;155:264-271.
44. Carmin CN, Wiegartz PS, Yunus U, Gillock KL. Treatment of late-onset OCD following basal ganglia infarct. Depress Anxiety 2002;15:87-90.
45. Perlmutter SJ, Leitman SF, Garvey MA, et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 1999;354: 1153-1158.
46. Garvey MA, Perlmutter SJ, Allen AJ, et al. A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 1999;45: 1564-1571.
47. Snider LA, Lougee L, Slattery M, et al. Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry 2005;57:788-792.
48. Gabbay V, Coffey BJ, Babb JS, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcus: comparison of diagnosis and treatment in the community and at a specialty clinic. Pediatrics 2008;122:273-278.
49. Shulman ST. Pediatric autoimmune neuropsychiatric disorders associated with streptococci (PANDAS): Update. Curr Opin Pediatr 2009;21:127-130.
50. Leckman JF, Bloch MH, King RA. Symptom dimensions and subtypes of obsessive-compulsive disorder: A developmental perspective. Dialogues Clin Neurosci 2009;11:21-33.
51. Leonard HL, Lenane MC, Swedo SE, et al. Tics and Tourette's disorder: A 2- to 7-year follow-up of 54 obsessive-compulsive children. Am J Psychiatry 1992;149:1244-1251.
52. George MS, Trimble MR, Ring HA, Sallee FR, Robertson MM. Obsessions in obsessive compulsive disorder with and without Gilles de la Tourette's syndrome. Am J Psychiatry 1993;150:93-97.
53. Leckman JF, Grice DE, Barr LC, et al. Tic-related vs. nontic-related obsessive compulsive disorder. Anxiety 1994;1: 208-215.
54. Holzer J, Goodman WK, Price LH, et al. Obsessive-compulsive disorder with and without a chronic tic disorder. A comparison of symptoms in 70 patients. Br J Psychiatry 1994;164:469-473.
55. Pauls DL, Alsobrook J, Goodman W, et al. A family study of obsessive compulsive disorder. Am J Psychiatry 1995;152:76-84.
56. Zohar AH, Pauls DL, Ratzoni G, et al. Obsessive-compulsive disorder with and without tics in an epidemiological sample of adolescents. Am J Psychiatry 1997;154:274-276.
57. Cath DC, Spinhoven P, Hoogduin CAL, et al. Repetitive behaviours in Tourette's syndrome and OCD with and without tics: What are the differences? Psychiatry Res 2001;101:171-185.
58. Eichstedt JA, Arnold SL. Childhood-onset obsessive-compulsive disorder: A tic-related subtype of OCD? Clin Psychol Rev 2001;21:137-157.
59. Nestadt G, Samuels J, Riddle M, et al. A family study of obsessive-compulsive disorder. Arch Gen Psychiatry 2000;57:358-363.
60. Grados MA, Riddle MA, Samuels JF, et al. The familial phenotype of obsessive-compulsive disorder in relation to tic disorders: The Hopkins OCD family study. Biol Psychiatry 2001;50:559-565.
61. do Rosario-Campos MC, Leckman JF, Curi M, et al. A family study of early-onset obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 2005;136B:92-97.
62. Diniz JB, Rosario-Campos MC, Hounie AG, et al. Chronic tics and Tourette syndrome in patients with obsessive-compulsive disorder. J Psychiatr Res 2006;40:487-493.
63. Jaisoorya TS, Reddy YC, Srinath S, Thennarasu K. Obsessive-compulsive disorder with and without tic disorder: A comparative study from India. CNS Spectr 2008;13:705-711.
64. Nestadt G, Di CZ, Riddle MA, Grados MA, et al. Obsessive-compulsive disorder: Subclassification based on co-morbidity. Psychol Med 2009;39:1491-1501.
65. de Mathis A, Diniz JA, Shavitt RG, et al. Early onset Obsessive-compulsive disorder with and without tics. CNS Spectr In press.
66. Leckman JF, Walker W K, Goodman WK, et al. "Just right" perceptions associated with compulsive behaviors in Tourette's syndrome. Am J Psychiatry 1994;151:675-680.
67. Miguel EC, do Rosário-Campos MC, Prado HS, et al. Sensory phenomena in obsessive-compulsive disorder and Tourette's disorder. J Clin Psychiatry 2000;61:150-156.
68. Prado HS, Rosário MC, Lee J, Hounie AG, Shavitt RG, Miguel EC. Sensory phenomena in obsessive-compulsive disorder and tic disorders: A review of the literature. CNS Spectr 2008;13:425-432.
69. Baer L. Factor analysis of symptom subtypes of obsessive-compulsive disorder and their relation to personality and tic disorders. J Clin Psychiatry 1994;55:18-23.
70. Leckman JF, Grice DE, Boardman J, et al. Symptoms of obsessive-compulsive disorder. Am J Psychiatry 1997;154: 911-919.
71. Hanna GL. Demographic and clinical features of obsessive-compulsive disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry 1995;34:19-27.
72. Stewart SE, Jenike MA, Keuthen NJ. Severe obsessive-compulsive disorder with and without comorbid hair pulling: Comparisons and clinical implications. J Clin Psychiatry 2005;66: 864-869.
73. Peterson BS, Pine DS, Cohen P, Brook JS. Prospective, longitudinal study of tic, obsessive-compulsive, and attentiondeficit/hyperactivity disorders in an epidemiological sample. J Am Acad Child Adolesc Psychiatry 2001;40:685-695.
74. Pauls DL. The genetics of obsessive compulsive disorder: A review of the evidence. Am J Med Genet C Semin Med Genet 2008;148:133-139.
75. Geller DA. Obsessive-compulsive and spectrum disorders in children and adolescents. Psychiatr Clin North Am 2006;29: 353-370.
76. Storch EA, Merlo LJ, Larson MJ, et al. Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 2008;47:583-592.
77. March JS, Franklin ME, Leonard H, et al. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry 2007;61:344-347.
78. McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH. The efficacy of fluvoxamine in obsessive-compulsive disorder: Effects of comorbid chronic tic disorder. J Clin Psychopharmacol 1993;13:354-358.
79. Shavitt RG, Belotto C, Curi M, et al. Clinical features associated with treatment response in obsessive-compulsive disorder. Compr Psychiatry 2006;47:276-281.
80. Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF. A systematic review: Antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 2006;11:622-632. (Pubitemid 43989810)
81. Ipser JC, Carey P, Dhansay Y, et al. Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders. Cochrane Database Syst Rev 2006;4:CD005473
82. Bloch MH, Peterson BS, Scahill L, et al. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Arch Pediatr Adolesc Med 2006;160: 65-69.
83. Bloch MH, Craiglow BG, Landeros-Weisenberger A, et al. Predictors of early adult outcomes in pediatric-onset obsessive-compulsive disorder. Pediatrics 2009;124:1085-1093.
84. Mataix-Cols D, Pertusa A, Leckman JF. Issues for DSM-V: How should obsessive-compulsive disorder be classified? Am J Psychiatry 2007;164:1313-1314.
85. Kalra SK, Swedo SE. Children with obsessive-compulsive disorder: are they just "little adults"? J Clin Invest 2009;119: 737-746.
86. Swedo SE, Rapoport JL, Leonard H, et al. Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases. Arch Gen Psychiatry 1989;46:335-341.
87. Geller DA, Biederman J, Faraone S, et al. Developmental aspects of obsessive compulsive disorder: Findings in children, adolescents, and adults. J Nerv Ment Dis 2001;189:471-477.
88. Reddy YC, Srinath S, Prakash HM, et al. A follow-up study of juvenile obsessive-compulsive disorder from India. Acta Psychiatr Scand 2003;107:457-464.
89. Mancebo MC, Garcia AM, Pinto A, et al. Juvenile-onset OCD: Clinical features in children, adolescents and adults. Acta Psychiatr Scand 2008;118:149-159.
90. Masi G, Millepiedi S, Mucci M, et al. A naturalistic study of referred children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 2005;44:673-681.
91. Tükel R, Ertekin E, Batmaz S, et al. Influence of age of onset on clinical features in obsessive-compulsive disorder. Depress Anxiety 2005;21:112-117.
92. Janowitz D, Grabe HJ, Ruhrmann S, et al. Early onset of obsessive-compulsive disorder and associated comorbidity. Depress Anxiety 2009;26:1012-1017.
93. Bloch MH, Landeros-Weisenberger A, Rosario-Campos MC, et al. Systematic review of the factor structure of obsessive-compulsive disorder. Am J Psychiatry 2008;165:1532-1542.
94. Noshirvani HF, Kasvikis Y, Marks IM, et al. Gender-divergent aetiological factors in obsessive-compulsive disorder. Br J Psychiatry 1991;158:260-263.
95. Castle DJ, Deale A, Marks IM. Gender differences in obsessive compulsive disorder. Aust N Z J Psychiatry 1995;29:114-117.
96. Stewart SE, Geller DA, Jenike M, et al. Long-term outcome of pediatric obsessive-compulsive disorder: A meta-analysis and qualitative review of the literature. Acta Psychiatr Scand 2004;110:4-13.
97. Fyer AJ, Lipsitz JD, Mannuzza S, et al. A direct interview family study of obsessive-compulsive disorder. I. Psychol Med 2005;35:1611-1621.
98. Lipsitz JD, Mannuzza S, Chapman TF, et al. A direct interview family study of obsessive-compulsive disorder. II. Contribution of proband informant information. Psychol Med 2005;35: 1623-1631.
99. Hemmings SM, Kinnear CJ, Lochner C, et al. Early-versus lateonset obsessive-compulsive disorder: Investigating genetic and clinical correlates. Psychiatry Res 2004; 128:175-182. (Pubitemid 39369869)
100. Carter AS, Pollock RA, Suvak MK, Pauls DL. Anxiety and major depression comorbidity in a family study of obsessive-compulsive disorder. Depress Anxiety 2004;20:165-174.
101. MacMaster FP, O'Neill J, Rosenberg DR. Brain imaging in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 2008;47:1262-1272.
102. Saxena S, Rauch SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am 2000;23:563-586.
103. Harrison BJ, Soriano-Mas C, Pujol J, et al. Altered corticostriatal functional connectivity in obsessive-compulsive disorder. Arch Gen Psychiatry 2009;66:1189-1200.
104. Rotge JY, Langbour N, Guehl D, et al. Gray matter alterations in obsessive-compulsive disorder: An anatomic likelihood estimation meta-analysis. Neuropsychopharmacology 2009 Nov 4. [Epub ahead of print].
105. Busatto GF, Buchpiguel CA, Zamignani DR, et al. Regional cerebral blood flow abnormalities in early-onset obsessive-compulsive disorder: an exploratory SPECT study. J Am Acad Child Adolesc Psychiatry 2001;40:347-354.
106. Gilbert AR, Akkal D, Almeida JR, et al. Neural correlates of symptom dimensions in pediatric obsessive-compulsive disorder: a functional magnetic resonance imaging study. J Am Acad Child Adolesc Psychiatry 2009;48:936-944.
107. Evans DW, Leckman JF, Carter A, et al. Ritual, habit, and perfectionism: The prevalence and development of compulsive like behavior in normal young children. Child Dev 1997;68:58-68.
108. Zohar AH, Felz L. Ritualistic behavior in young children. J Abnorm Child Psychol 2001;29:121-128.
109. Leckman JF, King RA, Cohen DJ. Tics and tic disorders. In: Leckman JF, Cohen DJ, editors. Tourette's Syndrome Tics, Obsessions, Compulsions - Developmental Psychopathology and Clinical Care. New York: Wiley; 1998:23-42.
110. Mell LK, Davis RL, Owens D. Association between streptococcal infection and obsessive-compulsive disorder. Tourette's syndrome, and tic disorder. Pediatrics 2005;116:56-60.
111. Leslie DL, Kozma L, Martin A, et al. Neuropsychiatric disorders associated with streptococcal infection: A case-control study among privately insured children. J Am Acad Child Adolesc Psychiatry 2008;47:1166-1172.
112. Luo F, Leckman JF, Katsovich L, et al. Prospective longitudinal study of children with tic disorders and/or obsessive-compulsive disorder: Relationship of symptom exacerbations to newly acquired streptococcal infections. Pediatrics 2004;113: e578-e585.
113. Perrin EM, Murphy ML, Casey JR, et al. Does group A X-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children? Arch Pediatr Adolesc Med 2004;158:848-856.
114. Kurlan R, Johnson D, Kaplan EL, and the Tourette Syndrome Study Group. Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: A prospective blinded cohort study. Pediatrics 2008;121:1188-1197.
115. Lin H, Williams KA, Katsovich L, et al. Streptococcal upper respiratory tract infections and psychosocial stress predict future tic and obsessive-compulsive symptom severity in children and adolescents with Tourette syndrome and/or obsessive-compulsive disorder. Biol Psychiatry 2009 Oct 13. [Epub ahead of print].
116. Hounie AG, Pauls DL, do Rosario-Campos MC, et al. Obsessive-compulsive spectrum disorders and rheumatic fever: A family study. Biol Psychiatry 2007;61:266-272.
117. Hoekstra PJ, Manson WL, Steenhuis M-P, et al. Association of common cold with exacerbations in pediatric but not adult patients with tic disorder: A prospective longitudinal study. J Child Adolesc Psychopharm 2005;15:285-292.
118. Ercan TE, Ercan G, Severge B, et al. Mycoplasma pneumoniae infection and obsessive-compulsive disease: A case report. J Child Neurol 2008;23:338-340.
119. Church AJ, Dale RC, Lees AJ, et al. Tourette's syndrome: A cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry 2003;74:602-607.
120. Kirvan CA, Swedo SE, Snider LA, Cunningham MW. Antibody-mediated neuronal cell signaling in behavior and movement disorders. J Neuroimmunol 2006;179:173-179
121. Kansy JW, Katsovich L, McIver KS, et al. Identification of pyruvate kinase as an antigen associated with Tourette syndrome. J Neuroimmunol 2006;181:165-176.
122. Cunningham MW, Kirvan C, Brimberg L, et al. Autoimmunity and behavior: Sydenham's chorea and related disorders. J Neuroimmunol 2008;203:204.
123. Singer HS, Gause C, Morris C, et al. Serial immune markers do not correlate with clinical exacerbations in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Pediatrics 2008;121:1198-1205.
124. Martino D, Dale RC, Gilbert DL, et al. Immunopathogenic mechanisms in Tourette syndrome: A critical review. Mov Disord 2009;24:1267-1279.
125. Giedd JN, Rapoport JL, Garvey MA, Perlmutter S, Swedo SE. MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection. Am J Psychiatry 2000;157:281-283.
126. Singer HS, Mink JW, Loiselle CR, et al. Microinfusion of antineuronal antibodies into rodent striatum: Failure to differentiate between elevated and low titers. J Neuroimmunol 2005;163:8-14.
127. Yaddanapudi K, Hornig M, Serge R, et al. Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Mol Psychiatry 2009 Aug 11. [Epub ahead of print].
128. Gilbert DL, Kurlan RM. PANDAS: Horse or zebra. Neurology 2009;73:1252-1253.
129. Regier DA. Dimensional approaches to psychiatric classification: Refining the research agenda for DSM-V: An introduction. Int J Methods Psychiatr Res 2007;16:S1-S5.
130. Mataix-Cols D, Rosario-Campos MC, Leckman JF. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 2005;162:228-238.
131. Leckman JF, Rauch SL, Mataix-Cols D. Symptom dimensions in obsessive-compulsive disorder: Implications for the DSM-V. CNS Spectr 2007;12:376-387, 400.
132. Rosario-Campos MC, Miguel EC, Quatrano S, et al. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): An instrument for assessing obsessive-compulsive symptom dimensions. Mol Psychiatry 2006;11:495-504.
133. Summerfeldt LJ, Richter MA, Antony MM, Swinson RP. Symptom structure in obsessive-compulsive disorder: A confirmatory factor-analytic study. Behav Res Ther 1999;37:297-311.
134. Pinto A, Greenberg BD, Grados MA, et al. Further development of YBOCS dimensions in the OCD collaborative genetics study: Symptoms vs. categories. Psychiatry Res 2008; 160:83-93.
135. Mathews CA, Andresen M, Cath D, et al. Latent structures and latent classes in obsessive compulsive disorder. Presented at the World Congress of Psychiatric Genetics 2009.
136. Rettew DC, Swedo SE, Leonard HL, et al. Obsessions and compulsions across time in 79 children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1992;31:1050-1056.
137. Mataix-Cols D, Rauch SL, Baer L, Eisen JL, et al. Symptom stability in adult obsessive-compulsive disorder: Data from a naturalistic two-year follow-up study. Am J Psychiatry 2002; 159:263-268.
138. Fullana MA, Tortella-Feliu M, Caseras X, et al. Temporal stability of obsessive-compulsive symptom dimensions in an undergraduate sample: A prospective 2-year follow-up study. Behav Modif 2007;31:815-824.
139. Hasler G, LaSalle-Ricci VH, Ronquillo JG, et al. Obsessive-compulsive disorder symptom dimensions show specific relationships to psychiatric comorbidity. Psychiatry Res 2005;135:121-132.
140. Coles ME, Pinto A, Mancebo MC, et al. OCD with comorbid OCDP: A subtype of OCD? J Psychiatr Res 2008;42:289-296.
141. Samuels JF, Bienvenu 3rd OJ, Pinto A, et al. Hoarding in obsessive-compulsive disorder: Results from the OCD Collaborative Genetics Study. Behav Res Ther 2007;45:673-686.
142. Mataix-Cols D, Baer L, Rauch SL, Jenike MA. Relation of factor-analyzed symptom dimensions of obsessive-compulsive disorder to personality disorders. Acta Psychiatr Scand 2000;02:199-202.
143. Wheaton M, Timpano KR, Lasalle-Ricci VH, Murphy D. Characterizing the hoarding phenotype in individuals with OCD: associations with comorbidity, severity and gender. J Anxiety Disord 2008;22:243-252.
144. van Grootheest DS, Boomsma DI, Hettema JM, Kendler KS. Heritability of obsessive-compulsive symptom dimensions. Am J Med Genet B Neuropsychiatr Genet 2008;147B:473-478.
145. Alsobrook II JP, Leckman JF, Goodman WK, et al. Segregation analysis of obsessive-compulsive disorder using symptom-based factor scores. Am J Med Genet 1999;88:669-675.
146. Leckman JF, Pauls DL, Zhang H, et al. Obsessive-compulsive symptom dimensions in affected sibling pairs diagnosed with Gilles de la Tourette syndrome. Am J Med Genet B Neuropsychiatr Genet 2003;116:60-68.
147. Hasler G, Pinto A, Greenberg BD, et al. Familiality of factor analysis-derived YBOCS dimensions in OCD-affected sibling pairs from the OCD Collaborative Genetics Study. Biol Psychiatry 2007;61:617-625.
148. Simpson HB, Rosen W, Huppert JD, et al. Are there reliable neuropsychological deficits in obsessive-compulsive disorder? J Psychiatr Res 2006;40:247-257.
149. Menzies L, Chamberlain SR, Laird AR, et al. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: The orbitofronto-striatal model revisited. Neurosci Biobehav Rev 2008;32:525-549.
150. Chamberlain SR, Menzies L, Hampshire A, et al. Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science 2008;321:421-422.
151. Lawrence NS, Wooderson S, Mataix-Cols D, et al. Decision making and set shifting impairments are associated with distinct symptom dimensions in obsessive-compulsive disorder. Neuropsychology 2006;20:409-419.
152. Goldman BL, Martin ED, Calamari JE, et al. Implicit learning, thought-focused attention and obsessive-compulsive disorder: a replication and extension. Behav Res Ther 2008;46:48-61.
153. Nedeljkovic M, Kyrios M, Moulding R, et al. Differences in neuropsychological performance between subtypes of obsessive-compulsive disorder. Aust N Z J Psychiatry 2009;43:216-226.
154. Rauch SL, Dougherty DD, Shin LM, et al. Neural correlates of factor-analyzed OCD symptom dimension: A PET study. CNS Spectr 1998;3:37-43.
155. Phillips ML, Marks IM, Senior C, et al. A differential neural response in obsessive-compulsive patients with washing compared with checking symptoms to disgust. Psychol Med 2000;30:1037-1050.
156. Shapira NA, Liu Y, He AG, et al. Brain activation by disgustinducing pictures in obsessive-compulsive disorder. Biol Psychiatry 2003;54:751-756.
157. van den Heuvel OA, Veltman DJ, Groenewegen HJ, et al. Amygdala activity in obsessive-compulsive disorder with contamination fear: A study with oxygen-15 water positron emission tomography. Psychiatry Res 2004;132:225-237.
158. Saxena S, Brody AL, Maidment KM, et al. Cerebral glucose metabolism in obsessive-compulsive hoarding. Am J Psychiatry 2004;161:1038-1048.
159. Mataix-Cols D, Wooderson S, Lawrence N, et al. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry 2004;61:564-576.
160. Lawrence NS, An SK, Mataix-Cols D, et al. Neural responses to facial expressions of disgust but not fear are modulated by washing symptoms in OCD. Biol Psychiatry 2007;61: 1072-1080.
161. Rauch SL, Wedig MM, Wright CI, et al. Functional magnetic resonance imaging study of regional brain activation during implicit sequence learning in obsessive-compulsive disorder. Biol Psychiatry 2007;61:330-336.
162. Pujol J, Soriano-Mas C, Alonso P, et al. Mapping structural brain alterations in obsessive-compulsive disorder. Arch Gen Psychiatry 2004;61:720-730.
163. van den Heuvel OA, Remijnse PL, Mataix-Cols D, et al. The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. Brain 2009;132:853-868.
164. Rachman SJ, Hodgson RJ. Obsessions and Compulsions. Englewood Cliffs, NJ: Prentice-Hall; 1980.
165. Abramowitz JS, Franklin ME, Foa EB. Empirical statusofcognitive- behavioral therapy for obsessive-compulsive disorder: A metaanalytic review. Rom J Cogn Behav Psychother 2002;2:89-104.
166. Mataix-Cols D, Marks IM, Greist JH, et al. Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy. Psychother Psychosom 2002;71:255-262.
167. Abramowitz JS, Franklin ME, Schwartz SA, Furr JM. Symptom presentation and outcome of cognitive-behavioral therapy for obsessive-compulsive disorder. J Consult Clin Psychol 2003; 71:1049-1057.
168. Soomro GM, Altman D, Rajagopal S, Oakley-Browne M. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev 2008 Jan 23:CD001765.
169. Bloch MH, McGuire J, Landeros-Weisenberger A, et al. Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Mol Psychiatry 2009 May 26. [Epub ahead of print].
170. Pallanti S, Quercioli L. Treatment-refractory obsessive-compulsive disorder: Methodological issues, operational definitions and therapeutic lines. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:400-412.
171. Black DW, Monahan P, Gable J, et al. Hoarding and treatment response in 38 nondepressed subjects with obsessive-compulsive disorder. J Clin Psychiatry 1998;59:420-425.
172. Winsberg ME, Cassic KS, Koran LM. Hoarding in obsessive-compulsive disorder: A report of 20 cases. J Clin Psychiatry 1999;60:591-597.
173. Mataix-Cols D, Rauch SL, Manzo PA, et al. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry 1999;156:1409-1416.
174. Saxena S, Brody AL, Maidment KM, Baxter Jr LR. Paroxetine treatment of compulsive hoarding. J Psychiatr Res 2007;41: 481-487.
175. Alonso MP, Menchón JM, Pifarré J, et al. Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy. J Clin Psychiatry 2001;62:535-540.
176. Shetti CN, Reddy YC, Kandavel T, et al. Clinical predictors of drug nonresponse in obsessive-compulsive disorder. J Clin Psychiatry 2005;66:1517-1523.
177. Ferrão YA, Shavitt RG, Bedin NR, et al. Clinical features associated to treatment response in obsessive-compulsive disorder. J Affect Disord 2006;94:199-209.
178. Stein DJ, Andersen EW, Overo KF. Response of symptom dimensions in obsessive-compulsive disorder to treatment with citalopram or placebo. Revista Bras Psiquiatr 2007;29:303-307.
179. Stein DJ, Carey PD, Lochner C, et al. Escitalopram in obsessive-compulsive disorder: Response of symptom dimensions to pharmacotherapy. CNS Spectrums 2008;6:492-498.
180. Matsunaga H, Nagata T, Hayashida K, et al. A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder. J Clin Psychiatry 2009;70:863-868.
181. Landeros-Weisenberger A, Bloch MH, Pittenger C, Leckman JF. Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder. J Affect Dis 2009 Jul 2. [Epub ahead of print].
182. Storch EA, Lack C, Merlo LJ, et al. Associations between miscellaneous symptoms and symptom dimensions: An examination of pediatric obsessive-compulsive disorder. Behav Res Ther 2007;45:2593-2603.
183. Storch EA, McNamara J, Jordan C, et al. Associations between miscellaneous symptoms and symptom dimensions in adults with obsessive-compulsive disorder. Anxiety Stress Coping 2008;21:199-212.
184. McKay D, Abramowitz JS, Calamari JE, et al. A critical evaluation of obsessive-compulsive disorder subtypes: Symptoms versus mechanisms. Clin Psychol Rev 2004;24: 283-313.
185. McKay D, Neziroglu F. Methodological issues in the obsessive-compulsive spectrum. Psychiatry Res 2009;170:61-65.